Allergy Therapeutics Interim Results for the six months ended 31 December 2019
March 04, 2020 07:00 ET
|
Allergy Therapeutics
Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”)Interim Results for the six months ended 31 December 2019 Record level of operating profit pre R&D supported by strong...
Allergy Therapeutics plc - Successful litigation settlement relating to PQ Grass Phase II Trial
June 27, 2019 10:47 ET
|
Allergy Therapeutics
Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”) Successful litigation settlement relating to PQ Grass Phase II Trial 27 June 2019 Allergy Therapeutics plc (AIM: AGY), the...
Allergy Therapeutics plc - Trading Update and Successful Litigation Settlement
June 27, 2019 10:26 ET
|
Allergy Therapeutics
Allergy Therapeutics plc(“Allergy Therapeutics” or the “Group”) Trading Update and Successful Litigation Settlement 2019 full year earnings expected to be ahead of market expectations 27 June...
Allergy Therapeutics PLC: Trading Update
July 12, 2018 07:00 ET
|
Allergy Therapeutics
Allergy Therapeutics plc(“Allergy Therapeutics” or the “Group”) Trading update Group’s market share continues to grow 12 July 2018 Allergy Therapeutics plc (AIM: AGY), the fully integrated...